Concentrations	12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]
Concentrations	Note L - Concentrations The Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2021, of which two licensees constituted an aggregate of 99% of the Company’s revenue for such year.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI https://asc.fasb.org/topic&trid=2134479

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration